DAYTONA BEACH, FL — (Marketwired) — 06/06/13 — (OTCQB: QUTR) announced today a sale of the first application of the QualOptima product to Springhill Medical Center (SMC), Springhill, LA. The new license to QualOptima transitions SMC-s former peer review product by Quture to performance measurement as the initial application of the QualOptima Analytics & Connectivity System on the InterSystems platform. The QualOptima System is the complete solution for “transformative and disruptive” technology to enhance clinical performance and achieve optimal patient outcomes. Quture announced on May 9, 2013 target marketing of QualOptima in June for commercial sales and installations. Quture is installing the QualOptima product and combined products of New Health Analytics, Richmond, VA. This sale demonstrates customer satisfaction to not only renew Quture-s former product, but to replace it with the enhanced peer review tools to accomplish the requirements of clinical performance and outcomes measurement with the new QualOptima product. The user advantages have now been proven to a long-established customer of Quture for the commercialization of the QualOptima Analytics and Connectivity System. Consistent with healthcare software market practices, the details of the sale were not disclosed.
Quture is leveraging its first mover position to transition from peer review to clinical performance and outcomes measurement in the healthcare analytics market. The return on investment (ROI) calculations for QualOptima justify potential sales to over 5,000 U.S. hospitals at a median price point for a total market potential of more than $750 million per year. The market potential was originally estimated in excess of $500 million in the United States alone. The healthcare analytics market is growing at 27% per year and is predicted to be $10.8 billion in 2015, so the market significantly exceeds this original projection. Quture continues to evaluate market penetration potentials, which the Company believes to be unlimited, in an increasingly competitive market. QualOptima, as a cloud application, strengthens Quture-s first mover position in the healthcare market as previously announced.
The new QualOptima Analytics & Connectivity System installs Quture-s Application Partnership with InterSystems tools: the Ensemble interface engine, Cache object-oriented database, DeepSee data display and Zen report writer, now strengthened by Active Analytics. SMC will be empowered by these InterSystems tools for dashboards, visual analytics and enhanced reports, as well as the advanced technology to capture data from disparate databases in a superior database. Natural language processing (NLP) tools of InterSystems iKnow and other Quture NLP proprietary licenses further develop the new application as the complete solution for actionable insight to improve care while reducing costs. The sale further advances joint marketing and sales with the combined products of New Health Analytics (NHA), as announced on April 16, 2013. The installation demonstrates the advantages of combining Quture-s clinical performance and outcomes analytics with NHA analytics from administrate data and state data sets. Capturing data electronically to reduce FTE manual processes, new search and data capture tools, and Quture-s extensive experience, expertise and metrics to measure clinical performance are essential for the regulatory and compliance demands for the emerging hospital and physician groups market.
“The core competence of Quture to measure and analyze clinical performance using extensive clinical metrics developed for more than 37 years is embedded in this QualOptima application,” said Landon Feazell, CEO of Quture International. “We are excited that our existing customers are already transitioning to the new QualOptima product at time of license renewal. The potential for market recognition through statewide initiatives, such as those in Louisiana, are extremely promising and create dramatic opportunities for sales and market penetration. The QualOptima system solves compliance challenges while implementing true enterprise management beyond business intelligence to empower clinical performance enhancement to achieve optimal patient outcomes.”
()
Quture International, Inc. () is the proven and experienced performance and outcomes analytics company in the United States. The vision of Quture is to connect all constituents in the global health and health care community to clinically and financially focused and sound data transformed through analytics to knowledge that . As a “Breakthrough” Application Partner of InterSystems Corporation, Quture-s technology for capturing, integrating and aggregating data on the InterSystems Enterprise platform is unequalled. The Company-s unique product QualOptima develops a second generation CLINICAL database implementing Quture-s core competence of clinical content with evidence-based metrics developed for more than 35 years. QualOptima empowers clinical performance enhancement to achieve optimal patient outcomes. Quture-s brand is centered on the value proposition of trust, transparency and independence. As the free enterprise solution to improving health and healthcare while reducing costs, Quture is positioned to become the leading clinical knowledge company in the world. Quture International is a Nevada corporation trading under the symbol QUTR.
()
Springhill Medical Center is a 58 bed facility offering Medical/Surgical, Geriatric Psychiatric, ICU, and ER services. In addition Springhill Medical Center offers full service Lab, X-Ray, Physical Therapy and Respiratory departments. Two Rural Health Clinics are home to 10 full-time healthcare providers and various other specialty providers that come on a regular basis. The medical center serves a large area of northwest Louisiana and parts of Arkansas. SMC-s mission is “Patient Centered Care From Our Family To Yours.” SMC-s vision is “To be every patient-s fist choice for healthcare excellence. We will adapt and expand services to create healthier communities.”
This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law. There is no assurance that a definitive agreement will be completed.
Mele Telitz
Director of Communications
855.740.QUTR (7878)
Infinity Advisors
Mark Kroeger
+1 (239) 495-6125
You must be logged in to post a comment Login